# How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention

Study · id `cardio:ct-nct01519518` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01519518](<https://clinicaltrials.gov/study/NCT01519518>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01519518

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1829 participants.

## Technical summary

Registry record NCT01519518. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-12 (actual). Results posted on 2015-04-22.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1829 participants (enrolled count; ClinicalTrials.gov record NCT01519518, source copy `cardio:ctgov-nct01519518-2015-05-13`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01519518, source copy `cardio:ctgov-nct01519518-2015-05-13`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01519518, source copy `cardio:ctgov-nct01519518-2015-05-13`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01519518, source copy `cardio:ctgov-nct01519518-2015-05-13`, retrieved 2026-10-26)
- Results first posted: 2015-04-22 (ClinicalTrials.gov record NCT01519518, source copy `cardio:ctgov-nct01519518-2015-05-13`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01519518, source copy `cardio:ctgov-nct01519518-2015-05-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01519518-2015-05-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
- Acronym: HEAT-PPCI
- Condition: Acute ST Elevation Myocardial Infarction
- Intervention (Drug): unfractionated heparin
- Intervention (Drug): Bivalirudin
- Lead sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Heparins and low-molecular-weight heparins (`cardio:heparins-and-low-molecular-weight-heparins`)
- Registry intervention name matches this record: Bivalirudin (`cardio:bivalirudin`)
- Registry intervention is a member of this class by a sourced record link: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as the lead sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust (`cardio:org-liverpool-heart-and-chest-hospital-nhs-foundation-trust`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial (`cardio:pubmed-25002178`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: bf836dd127ac839029d736fc315a88ca0a3e77c1a9de201ee7bdba16b3b51c81
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
